North America Diabetes Care Devices Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - Request a Free Sample

North America Diabetes Care Devices Market Overview

Diabetes care devices are evolving with technological advancements that enable more accurate monitoring, personalized treatment, and improved patient adherence. These innovations are strengthening long-term diabetes management across healthcare settings. The market was valued at USD 13.80 Billion in 2025, driven by the increasing healthcare spending and strong regulatory frameworks. The growing awareness of diabetes management and expanding access to advanced medical technologies are also expanding the market.

North America Diabetes Care Devices Market Growth Analysis and Key Influencers

North America Diabetes Care Devices Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

North America Diabetes Care Devices Market Growth Drivers

Rising Diabetes Prevalence to Boost the Market Expansion

The growing prevalence of diabetes is a primary factor driving the expansion of the market, as it continues to increase the demand for continuous glucose monitoring systems, insulin delivery devices, and blood glucose monitoring solutions. According to the Centers for Disease Control and Prevention (CDC), more than 40 million Americans, representing approximately one in eight individuals, have diabetes, with nearly 90% to 95% diagnosed with Type 2 diabetes. The increasing incidence among children, adolescents, and young adults further underscores the need for advanced diabetes management technologies, supporting sustained market expansion across North America.

North America Diabetes Care Devices Market Restraints

Product Recalls and Device Accuracy Concerns Hamper Market Value

Product recalls and concerns regarding device accuracy remain significant challenges for the market, as they can reduce patient confidence, increase regulatory oversight, and delay product adoption. For instance, in December 2025, Health Canada recalled certain Abbott FreeStyle Libre 3 Plus sensors after identifying the potential for incorrect low glucose readings that could result in inappropriate treatment decisions and serious health risks. Such incidents emphasize the critical importance of product reliability and quality assurance, creating barriers to the broader adoption of diabetes care devices.

North America Diabetes Care Devices Market Opportunities

Advancements in Integrated Diabetes Monitoring Technologies Create New Market Potential

Ongoing innovation in integrated diabetes monitoring technologies is creating significant opportunities for the market by improving clinical decision-making and patient outcomes. For instance, in May 2026, Abbott announced CE Mark approval for its Libre Duo system, the world's first dual glucose and ketone sensing technology that continuously monitors both biomarkers through a single wearable sensor. The integration of comprehensive metabolic monitoring with digital health platforms is expected to accelerate the adoption of next-generation diabetes care devices and support long-term market development.

North America Diabetes Care Devices Market Trends

The market is witnessing several trends including the advancement of continuous glucose monitoring technologies.

Growing Adoption of Next-Generation Continuous Glucose Monitoring Systems Strengthens Market Growth

The increasing adoption of next-generation continuous glucose monitoring (CGM) systems is transforming diabetes management by delivering greater accuracy, improved user convenience, and enhanced digital connectivity. For instance, in July 2023, Health Canada approved the Dexcom G7 Continuous Glucose Monitoring System, featuring faster sensor warm-up, improved accuracy, and seamless integration with digital health platforms. Such technological advancements are encouraging wider adoption of advanced diabetes management solutions and are expected to strengthen the long-term growth of the market.

North America Diabetes Care Devices Market Share

Type 2 Diabetes Segment is Expected to Maintain Market Leadership by Disease Type

The market is segmented by disease type into type 1 diabetes and type 2 diabetes. Among these, the type 2 diabetes segment is expected to dominate due to its substantially larger patient population and the growing demand for advanced glucose monitoring and diabetes management technologies. For instance, in July 2026, Dexcom became the first participant selected for the U.S. Food and Drug Administration's TEMPO Digital Health Devices Pilot Program to advance artificial intelligence-enabled glucose monitoring for prediabetes and Type 2 diabetes. This initiative is expected to accelerate innovation and reinforce the segment's leading position in the market.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - Request a Free Sample

North America Diabetes Care Devices Market Analysis by Region

The regions covered in the report include the United States and Canada. Among these, the United States is expected to account for the largest market share owing to its high diabetes burden, well-established healthcare infrastructure, and rapid adoption of advanced diabetes care technologies. For instance, in June 2026, the U.S. Food and Drug Administration cleared the first over-the-counter continuous glucose monitor for children aged two years and older, expanding access to innovative glucose monitoring solutions. Continued regulatory support and technological advancements are expected to reinforce the country's leadership in the market.

Leading Players in the North America Diabetes Care Devices Market

North America Diabetes Care Devices Market Segmentation

Key Questions Answered in the North America Diabetes Care Devices Market Report

• What was the North America diabetes care devices market value in 2025?
• What is the North America diabetes care devices market forecast outlook for 2026-2035?
• What are the major factors aiding the North America diabetes care devices market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major diabetes care devices market trends?
• Which product type is expected to dominate the market segment?
• Which disease type is projected to lead the market segment?
• Which patient care settings are anticipated to drive the market segment?
• Who are the key players involved in the North America diabetes care devices market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed using a comprehensive mixed-methods research approach that integrates both qualitative and quantitative analysis to provide reliable market insights. The methodology includes:

• Primary Research: In-depth interviews conducted with 30+ endocrinologists, diabetologists, diabetes educators, hospital procurement managers, diabetes specialty clinic administrators, medical device distributors, and industry executives across the United States and Canada to validate market trends, technology adoption, and purchasing patterns.
• Secondary Research: Peer-reviewed publications from Diabetes Care, The Lancet Diabetes & Endocrinology, and the Journal of Diabetes Science and Technology; regulatory data from the U.S. Food and Drug Administration (FDA) and Health Canada; epidemiological data from the Centers for Disease Control and Prevention (CDC), Public Health Agency of Canada (PHAC), National Institutes of Health (NIH), and company annual reports, investor presentations, product portfolios, press releases, and regulatory filings of leading manufacturers.
• Validation: All market estimates are verified through top-down and bottom-up market sizing models and further validated through expert interviews and multiple data triangulation techniques.

More Insights on

Management Decision Market